
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:33788</ns1:identifier>
    <ns1:title language="en">A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases</ns1:title>
    <ns2:alt_title language="sr">Prospektivna obzervaciona studija koja analizira dijagnostičku vrednost hepcidina-25 u anemiji kod pacijenata sa inflamatornim bolestima creva</ns2:alt_title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">ABSTRACT
Iron deficiency (IDA) and chronic disease (ACD) anemia are complications of inflammatory bowel diseases (IBDs). Therapeutic modalities in remission and active IBD depend on the type of anemia. This study evaluated the link between hepcidin-25, proinflammatory cytokines, and platelet activation markers as biomarkers of anemia and inflammation in active IBD and remission. This prospective observational study included 62 patients with IBD (49 with ulcerative colitis and 13 with Crohn’s) and anemia. Patients were divided into Group I (no or minimal endoscopic signs of disease activity and IDA), Group II (moderate and major endoscopic signs of disease activity and mild ACD), and Control group (10 patients with IBD in remission, without anemia). We assessed the difference among groups in the levels of CRP, hemoglobin (Hgb), serum iron, ferritin, hepcidin-25, interleukins, TNF–α, IFN-γ, soluble CD40 ligand, and sP-selectin. Hepcidin-25 levels were significantly higher in Group II versus Group I (11.93 vs. 4.48 ng/mL, p &lt; 0.001). Ferritin and CRP values showed similar patterns in IBD patients: significantly higher levels were observed in Group II (47.5 ng/mL and 13.68 mg/L) than in Group I (11.0 ng/mL and 3.39 mg/L) (p &lt; 0.001). In Group II, hepcidin-25 was positively correlated with ferritin (ρ = 0.725, p &lt; 0.001) and CRP (ρ = 0.502, p = 0.003). Ferritin was an independent variable influencing hepcidin-25 concentration in IBD patients, regardless of disease activity and severity of anemia. IBD hepcidin-25 best correlates with ferritin, and both parameters reflected inflammation extent and IBD activity.</ns1:description>
    <ns1:keyword language="en">hepcidin; ferritin; ulcerative colitis; Crohn’s disease; anemia; inflammation; cytokine</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>10.3390/ijms25073564</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2024-05-24T10:54:22.928Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Stanko</ns3:firstname>
        <ns3:lastname>Petrović</ns3:lastname>
        <ns3:institution>University of Defence,  Medical Faculty of the Military Medical Academy, Belgrade, Serbia</ns3:institution>
      </ns1:entity>
      <ns1:entity seq="8">
        <ns3:firstname>Dino</ns3:firstname>
        <ns3:lastname>Tarabar</ns3:lastname>      
  <ns3:institution>University Hospital Center “Dr. Dragiša Mišović”, Clinic for Gastroenterology, Belgrade, Serbia </ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="7">
        <ns3:firstname>Danica</ns3:firstname>
        <ns3:lastname>Ćujić</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor medicinskih nauka-farmacija</ns3:title1>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-6145-3850</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="6">
        <ns3:firstname>Dušica</ns3:firstname>
        <ns3:lastname>Stamenković</ns3:lastname>
        <ns3:institution>University of Defence,  Medical Faculty of the Military Medical Academy, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="5">
        <ns3:firstname>Marijana</ns3:firstname>
        <ns3:lastname>Petrović</ns3:lastname>
        <ns3:institution>University of Defence,  Medical Faculty of the Military Medical Academy, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="4">
        <ns3:firstname>Nemanja</ns3:firstname>
        <ns3:lastname>Rančić</ns3:lastname>
        <ns3:institution>University of Defence, Centre for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="3">
        <ns3:firstname>Vesna</ns3:firstname>
        <ns3:lastname>Subota</ns3:lastname>
        <ns3:institution>University of Defence, Institute of Medical Biochemistry, Military Medical Academy, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="2">
        <ns3:firstname>Nenad</ns3:firstname>
        <ns3:lastname>Perišić</ns3:lastname>
        <ns3:institution>University of Defence,  Medical Faculty of the Military Medical Academy, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="1">
        <ns3:firstname>Mihailo</ns3:firstname>
        <ns3:lastname>Bezmarević</ns3:lastname>
        <ns3:institution>University of Defence,  Medical Faculty of the Military Medical Academy, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>1403928</ns1:size>
    <ns1:location>https://phaidrabg.bg.ac.rs/o:33788</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>16</ns1:license>
    <ns2:infoeurepoaccess>1556227</ns2:infoeurepoaccess>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>92000001</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>11A29</ns8:faculty>
      <ns8:department>11A2910</ns8:department>
    </ns8:orgassignment>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">International Journal of Molecular Sciences</ns12:name_magazine>
    <ns12:volume>25</ns12:volume>
    <ns12:booklet>7</ns12:booklet>
    <ns12:publisher>MDPI</ns12:publisher>
    <ns12:releaseyear>2024</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
